- Home
- FLGC vs EVAX Comparison
FLGC vs EVAX Comparison
Compare FLGC & EVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FLGC
- EVAX
- Stock Information
- Founded
- FLGC 2019
- EVAX 2008
- Country
- FLGC United States
- EVAX Denmark
- Employees
- FLGC N/A
- EVAX N/A
- Industry
- FLGC Biotechnology: Pharmaceutical Preparations
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FLGC Health Care
- EVAX Health Care
- Exchange
- FLGC Nasdaq
- EVAX Nasdaq
- Market Cap
- FLGC 15.9M
- EVAX 15.1M
- IPO Year
- FLGC 2021
- EVAX 2021
- Fundamental
- Price
- FLGC $22.50
- EVAX $2.92
- Analyst Decision
- FLGC Strong Buy
- EVAX Strong Buy
- Analyst Count
- FLGC 1
- EVAX 2
- Target Price
- FLGC $156.00
- EVAX $10.00
- AVG Volume (30 Days)
- FLGC 15.8K
- EVAX 90.0K
- Earning Date
- FLGC 08-01-2025
- EVAX 10-30-2025
- Dividend Yield
- FLGC N/A
- EVAX N/A
- EPS Growth
- FLGC N/A
- EVAX N/A
- EPS
- FLGC N/A
- EVAX N/A
- Revenue
- FLGC $52,373,000.00
- EVAX $3,176,000.00
- Revenue This Year
- FLGC N/A
- EVAX N/A
- Revenue Next Year
- FLGC $10.22
- EVAX N/A
- P/E Ratio
- FLGC N/A
- EVAX N/A
- Revenue Growth
- FLGC N/A
- EVAX 1042.45
- 52 Week Low
- FLGC $15.15
- EVAX $1.20
- 52 Week High
- FLGC $82.29
- EVAX $17.75
- Technical
- Relative Strength Index (RSI)
- FLGC 52.11
- EVAX 51.71
- Support Level
- FLGC $21.70
- EVAX $2.52
- Resistance Level
- FLGC $22.95
- EVAX $2.85
- Average True Range (ATR)
- FLGC 1.63
- EVAX 0.21
- MACD
- FLGC 0.31
- EVAX -0.05
- Stochastic Oscillator
- FLGC 64.03
- EVAX 45.45
About FLGC Flora Growth Corp.
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are: the commercial and wholesale segment (FGH and Cosechemos subsidiaries) and the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries). Geographically, the company generates revenue from the United States, Germany, Australia, and the United Kingdom. It generates revenue as a distributor of pharmaceutical goods, and a manufacturer and reseller of a range of cannabis-based and complementary products.
About EVAX Evaxion Biotech
Evaxion AS is in the field of oncology. It used the AI-Immunology platform.